1-(4-Bromo-3-(trifluoromethyl)phenyl)piperidin-2-one

Catalog No. :
ACCJTP618
CAS No. :
1257664-90-6
Molecular Formula :
C12H11BrF3NO
Molecular Weight :
322.12

IUPAC Name:1-(4-bromo-3-(trifluoromethyl)phenyl)piperidin-2-one

1-(4-Bromo-3-(trifluoromethyl)phenyl)piperidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$117.00Login to see priceInquiryInquiry
1g98%$254.00Login to see priceInquiryInquiry
5g98%$644.00Login to see priceInquiryInquiry
10g98%$956.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromo-3-(trifluoromethyl)phenyl)piperidin-2-one
IUPAC Name1-(4-bromo-3-(trifluoromethyl)phenyl)piperidin-2-one
MDL No.MFCD04037069
Molecular FormulaC12H11BrF3NO
Molecular Weight322.12
SMILESO=C1N(C2=CC=C(Br)C(C(F)(F)F)=C2)CCCC1
InChI KeyLTVWQJQBGMWUKJ-UHFFFAOYSA-N
Synonym1257664-90-6 | 1-(4-Bromo-3-trifluoromethylphenyl)piperidin-2-one | 1-(4-Bromo-3-(trifluoromethyl)phenyl)piperidin-2-one | 1-[4-bromo-3-(trifluoromethyl)phenyl]piperidin-2-one | 1-(4-BROMO-3-TRIFLUOROMETHYL-PHENYL)-PIPERIDIN-2-ONE | DTXSID80682020 | MFCD04037069 | AKOS
CAS No.1257664-90-6
PubChem CID53216891

Synthetic Route by SureRoute

1. ACCJTP618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDZKL905 route compound structure diagram
    ACDZKL905364-11-4 In Stock
  2. Plus
  3. ACHGDV157 route compound structure diagram
    ACHGDV157675-20-7 In Stock
  4. Then
  5. ACCJTP618 route product structure diagram
    ACCJTP6181257664-90-6
Inquiry

2. ACCJTP618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFOPD463 route compound structure diagram
    ACFOPD4637657-09-2 In Stock
  2. Plus
  3. ACHGDV157 route compound structure diagram
    ACHGDV157675-20-7 In Stock
  4. Then
  5. ACCJTP618 route product structure diagram
    ACCJTP6181257664-90-6
Inquiry

Comments (0)